Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Cell-free Tumor DNA and Metabolites in Cerebrospinal Fluid as Early Biomarkers of Secondary CNS Involvement in Diffuse Large B-cell Lymphoma

NCT04112238 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT04112238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04112238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Cell-free Tumor DNA and Metabolites in Cerebrospinal Fluid as Early Biomarkers of Secondary CNS Involvement in Diffuse Large B-cell Lymphoma
Lead sponsor
Herlev Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 29, 2019
Completion date
June 1, 2023
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system metastasis, diffuse large b cell lymphoma